Coronaridine hydroxyindolenine






Names

    • methyl (1S,10R,15S,17S,18S)-17-ethyl-10-hydroxy-3,13-diazapentacyclo(13.3.1.02,10.04,9.013,18)nonadeca-2,4,6,8-tetraene-1-carboxylate
    • Methyl (1S,10R,15R,17S,18S)-17-ethyl-10-hydroxy-3,13-diazapentacyclo[13.3.1.0,.0,.0,]nonadeca-2,4,6,8-tetraene-1-carboxylic acid
    • Coronaridine hydroxyindolenine
    • methyl (1S,10R,15S,17S,18S)-17-ethyl-10-hydroxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2,4,6,8-tetraene-1-carboxylate
    • CHEMBL184480
    • CORONARIDINE HYDROXYINDOLENINE
    • 16671-16-2
    • BDBM50378855
    • Methyl (1S,10R,15R,17S,18S)-17-ethyl-10-hydroxy-3,13-diazapentacyclo(13.3.1.0,.0,.0,)nonadeca-2,4,6,8-tetraene-1-carboxylic acid

Attributes

  • Canonical SMILES

    CC[C@H]1C[C@H]2C[C@@]3([C@H]1N(C2)CC[C@@]4(C3=NC5=CC=CC=C54)O)C(=O)OC

  • InChI

    InChI=1S/C21H26N2O3/c1-3-14-10-13-11-20(19(24)26-2)17(14)23(12-13)9-8-21(25)15-6-4-5-7-16(15)22-18(20)21/h4-7,13-14,17,25H,3,8-12H2,1-2H3/t13-,14-,17-,20-,21+/m0/s1

  • Molecule Class: Alkaloids
  • TPSA: 62.129999999999995
  • #RotBonds: 2
  • MW: 354.4500000000001
  • HBD: 1
  • HBA: 5
  • logP: 2.6438000000000006
  • Chemical Formula: C21H26N2O3


Species

    Species Place of Collection NCBI Taxonomy Voucher Specimen
    T. bufalina China 403123 Cai20170220
    T. catharinensis Brazil 403124 UEC117862
    T. corymbosa Malaysia, China 1679252 GK604
    T. crassa Ghana 761062 20161116
    T. divaricata China, Japan, Thailand, Bangladesh, Vienna 52861 BBP0671
    T. heyneana India 2563820 -
    T. officinalis China - Cai20120227

External Databases


References

  • Alkaloids isolated from Tabernaemontana bufalina display xanthine oxidase inhibitory activity. Phytochemistry, 2019 (PMID 31302343).
  • A new alkaloid and other anti-implantation principles from Tabernaemontana heyneana. Planta Med, 2001 (PMID 11509989).
  • Bio-guided search of active indole alkaloids from Tabernaemontana catharinensis: Antitumour activity, toxicity in silico and molecular modelling studies. Bioorg Chem, 2019 (PMID 30599414).
  • Bisindole alkaloids from Tabernaemontana corymbosa. Phytochemistry, 2018 (PMID 29758521).
  • Chemical constituents antioxidant and anticholinesterasic activity of Tabernaemontana catharinensis. ScientificWorldJournal, 2013 (PMID 23983637).
  • Coronaridine, an iboga type alkaloid from Tabernaemontana divaricata, inhibits the Wnt signaling pathway by decreasing β-catenin mRNA expression. Bioorg Med Chem Lett, 2015 (PMID 26231157).
  • Cytotoxic indole alkaloids from Tabernaemontana officinalis. Phytochemistry, 2015 (PMID 25687604).
  • New Monoterpenoid Indole Alkaloids from Tabernaemontana crassa Inhibit β-Amyloid42 Production and Phospho-Tau (Thr217). Int J Mol Sci, 2023 (PMID 36675001).
  • Three New Indole Alkaloids from Tabernaemontana divaricata. Nat Prod Bioprospect, 2018 (PMID 29754315).
  • Virtual Screening of compounds from Tabernaemontana divaricata for potential anti-bacterial activity. Bioinformation, 2014 (PMID 24748755).

Compound-Protein Relationships

  • No relationship found

Compound Activities

    • Antibacterial
    • Uterotrophic
    • Xanthine oxidase inhibitory
    • Anticholinesterasic
    • Antitumor
    • Inhibitory
    • Antioxidant
    • Cytotoxicity
    • Cidal
    • Scavenging

Predicted NMR Spectral Data


Predicted MS Fragmentation Pattern

    N.B.: It is recommended to zoom in on a specific area of an MS plot before hovering on a peak.

Predicted ADMET Properties

    Property Model Name Predicted Value
    Absorption Caco-2 (logPaap) -4.66
    Human Oral Bioavailability 20% Bioavailable
    Human Intestinal Absorption Absorbed
    Madin-Darby Canine Kidney -4.84
    Human Oral Bioavailability 50% Bioavailable
    P-Glycoprotein Inhibitor Non-Inhibitor
    P-Glycoprotein Substrate Substrate
    Skin Permeability -2.17
    Distribution Blood-Brain Barrier (Central Nervous System) -2.14
    Blood-Brain Barrier Penetrable
    Fraction Unbound (Human) 0.78
    Plasma Protein Binding 57.74
    Steady State Volume of Distribution 2.65
    Metabolism Breast Cancer Resistance Protein Non-Inhibitor
    CYP 1A2 Inhibitor Inhibitor
    CYP 1A2 substrate Substrate
    CYP 2C19 Inhibitor Non-Inhibitor
    CYP 2C19 substrate Non-Substrate
    CYP 2C9 Inhibitor Non-Inhibitor
    CYP 2C9 Substrate Non-Substrate
    CYP 2D6 Inhibitor Inhibitor
    CYP 2D6 Substrate Substrate
    CYP 3A4 Inhibitor Inhibitor
    CYP 3A4 Substrate Substrate
    OATP1B1 Non-Inhibitor
    OATP1B3 Non-Inhibitor
    Excretion Clearance 6.33
    Organic Cation Transporter 2 Inhibitor
    Half-Life of Drug Half-Life < 3hs
    Toxicity AMES Mutagenesis Safe
    Avian Safe
    Bee Toxic
    Bioconcentration Factor -0.72
    Biodegradation Safe
    Carcinogenesis Safe
    Crustacean Toxic
    Liver Injury I Safe
    Eye Corrosion Safe
    Eye irritation Safe
    Maximum Tolerated Dose -0.95
    Liver Injury II Toxic
    hERG Blockers Safe
    Daphnia Maga 5.39
    Micronucleos Toxic
    NR-AhR Safe
    NR-AR Safe
    NR-AR-LBD Safe
    NR-Aromatase Safe
    NR-ER Safe
    NR-ER-LBD Safe
    NR-GR Safe
    NR-PPAR-gamma Safe
    NR-TR Safe
    T. Pyriformis -8.3
    Rat (Acute) 3.74
    Rat (Chronic Oral) 1.96
    Fathead Minnow 3.95
    Respiratory Disease Toxic
    Skin Sensitisation Safe
    SR-ATAD5 Safe
    SR-ARE Safe
    SR-HSE Safe
    SR-MMP Safe
    SR-p53 Safe
    General Properties Boiling Point 422.19
    Hydration Free Energy -3.44
    Log(D) at pH=7.4 2.37
    Log(P) 2.09
    Log S -3.16
    Log(Vapor Pressure) -7.95
    Melting Point 180.89
    pKa Acid 6.94
    pKa Basic 6.67